Associate Director, Field Business Lead - Rare Diseases

The Canadian Field Business Lead serves as Alnylam\u0027s primary customer-facing commercial representative in Canada, responsible for driving sales of OXLUMO and GIVLAARI. Working cross-functionally with marketing, patient services, market access, and medical affairs, this role leads local strategy execution while ensuring strong alignment between the Canadian market and the Global Rare team. The position reports to the Head of Sales, North America, is based in the Greater Toronto Area, and requires regular travel across Canada.\n\n \n\nKey Responsibilities\n\n * Commercial Execution: Drives implementation of local tactical plans \u2014 including HCP interactions, congresses, educational events, and customer outreach \u2014 to achieve sales targets. Develops account plans in partnership with Medical Affairs and North America Marketing and conducts detailed segmentation and targeting analysis to identify and develop key treatment centers and healthcare providers.\n * Customer \u0026 Stakeholder Engagement Builds and maintains sustainable relationships with healthcare stakeholders as the primary commercial partner for key customers in Canada. Represents Alnylam at local and national events and congresses.\n * Cross-Functional Collaboration: Collaborates with the North America marketing team on local strategy, brand planning, and multichannel tactics. Ensures best-in-class alignment with cross-functional colleagues across Canada and North America, and provides high-quality input into market access, forecasting, and brand investment planning.\n * Insights \u0026 Performance Management: Provides deep local market and stakeholder insights to inform both country-level and North American strategy. Tracks agreed KPIs to enable early course correction and ensure disciplined tactical execution, and partners with the Head of Sales on commercial investment planning and tracking. Delivers regular business plan and performance updates to leadership, ensuring transparency and alignment on progress against goals.\n * Leadership \u0026 Compliance: Holds direct responsibility for leading contracted and potential future internal sales employee(s) in Canada. Conducts all activities to the highest ethical standards in accordance with Alnylam policies, industry codes of practice, and applicable laws and regulations.\n\n\n\n \n\n \n\nQualifications\n\n \n\n * Experience in Pharmaceutical Sales, specifically key account management and sales leadership required\n * Experience in marketing is a plus\n * Experience with Rare and Ultra-Rare disease sales landscape required\n * Strong knowledge of reimbursement in the Canadian healthcare markets, particularly in the rare disease space is required\n * Education (Minimum) requirements: Life Science degree; Business degree a plus\n * Language (Minimum) requirements: Fluency in English, French is a plus\n * Strong network/matrix stakeholder communications skills \n * Strong business and financial acumen\n * Relentless external customer and patient focus\n * Ability to travel within across Canada frequently\n * Autonomous working style, pragmatic and operationally oriented, excellent planning and organizing skills\n\n\n\n \n\n#LI-Remote\n\nAbout Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by \u201cinterfering\u201d with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.\n\nOur culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we\u2019ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine\u2019s Top Biopharma Employers, one of America\u0027s Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK \u2013 among others.\n\nAt Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.\n